Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62.7M
-
Number of holders
-
197
-
Total 13F shares, excl. options
-
51.6M
-
Shares change
-
+82.4K
-
Total reported value, excl. options
-
$1.97B
-
Value change
-
+$2.02M
-
Put/Call ratio
-
0.2
-
Number of buys
-
86
-
Number of sells
-
-87
-
Price
-
$38.14
Significant Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q4 2022
234 filings reported holding SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") as of Q4 2022.
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) has 197 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.6M shares
of 62.7M outstanding shares and own 82.35% of the company stock.
Largest 10 shareholders include FMR LLC (6.55M shares), WELLINGTON MANAGEMENT GROUP LLP (5.52M shares), BlackRock Inc. (4.91M shares), VANGUARD GROUP INC (4.89M shares), Bellevue Group AG (2.97M shares), STATE STREET CORP (2.73M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.9M shares), JPMORGAN CHASE & CO (1.41M shares), DIMENSIONAL FUND ADVISORS LP (1.32M shares), and Boxer Capital, LLC (1.09M shares).
This table shows the top 197 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.